Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria
Crossref DOI link: https://doi.org/10.1007/s40121-018-0226-x
Published Online: 2018-12-11
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pugh, Sarah J.
Fletcher, Mark A.
Charos, Apostolos
Imekraz, Lynda
Wasserman, Matt
Farkouh, Raymond
Funding for this research was provided by:
Pfizer
Article History
Received: 11 September 2018
First Online: 11 December 2018